Ivermectin.. AND HCQ, Zinc, and Azithromycin (generic Zithromax).
Given soon enough— recovery. There are also the known D3 supplement, Zinc, Quercitin, and N-Acetyl Cysteine all relatively cheap dietary supplements which prevent S-Protein attachment to the ACE2 receptors on lung lining cells.
I think I would opt for the doxycycline over azythromycin. Doxycycline can pass the blood brain barrier.
Having COPD, I was interested in what was "S-Protein attachment" mentioned in your post. So I searched for it. The 4th item in the list had SARS-CoV in the title. It was dated 2009. I keyed in on the CoV and the SARS part didn't register with me. So I'm going 2009??? So I opened it.
Here's the article: The spike protein of SARS-CoV — a target for vaccine and therapeutic development
READ IT! Deja Freaking Vu!!! It's all there. It reads like they are talking about WuFlu. Bats, civits, spike proteins, the images, quarantines; the whole story we've been fed for the last year and a half. THEY KNEW IT ALL. Covid-19 is nothing "novel" unless you consider it to be the new and improved SARS. The minute they saw this "new" virus THEY KNEW EXACTLY WHAT WAS GOING ON.
Then there's this little snippet:
Although the outbreaks of SARS seem to be over, SARS is still a safety concern because of the possible reintroduction of a SL-CoV into humans and the risk of an escape of SARS-CoV from laboratories. [SL being SARS-like]Gee, ya think??? And look at the two footnotes for that sentence, both from 2004. An updated version of the article could include the State Department warning about the Wuhan lad practices.
THEY HAVE BEEN PLAYING WITH THIS FOR TEN YEARS.
They are banning NAC because it helped Covid patients. Going to make it prescription only. Just evil. Amazon already pulled it.
For what its worth.. Excerpt from TrailSite News..
The FLCC is best known for its MATH+ COVID-19 treatment protocol. On October 14, TrialSite reported that this protocol included an Ivermectin option for prevention and early treatment of COVID-19. On October 31, the group formalized a new protocol for both prevention and early treatment of COVID-19, this time dubbed, I-MASK+. The “I” stands for Ivermectin, which is now the key ingredient in the protocol rather than an option. FLCCC was formed as a working group of doctors recognizing the emergency conditions of the early pandemic in reaction to many reports of COVID-19 patients with inexplicable need for ventilation and the high death rate of the prevailing “supportive care only” recommendations from major healthcare organizations. This “group of highly published leaders in critical care,” led by Dr. Paul Marik had expertise in severe infections including bacterial sepsis. Along with high patient-survival numbers of those following the FLCC’s protocols, “equally concerned and motivated colleagues from other specialties” reached out to join the efforts. The MATH+ Hospital Treatment Protocol was formulated in March, and it has been used successfully since then for the severely ill. For more on the background of the FLCCCC alliance, follow the link.
“The I-MASK+ protocol will revolutionize the treatment of COVID-19”
As noted, I-MASK+ is a new protocol for both prophylaxis and early outpatient treatment of COVID-19 patients. It is, “centered around the use of Ivermectin, the FDA approved, well-known anti-parasite drug with the discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.” I-MASK+ and MATH+ are complementary in that the former excludes hospitalized patients while the later focuses on them. According to the FLCCC, all of their recommended medicines are, “FDA-approved, inexpensive, readily available and have been used for decades with well-established safety profiles.”